To our knowledge, this is the largest study conducted of the immunophenotypiccharacteristics of DLBCL in Kenya evaluating the prevalence of double expression andCOO, as well as the proportion of CD5- and CD30-positive cases. This evidence concerns the gene TNFRSF8 and diffuse large B-cell lymphoma.